Edwards Lifesciences target price raised to $114 from $103 by Raymond James
EW•Raymond James raised its target price for Edwards Lifesciences to $114 from $103.
Related News
Aemetis swings to Q3 net income of $5.2 million; revenues rise 49% to $88.2 million
AMTX•
Nextdoor Q3 revenue beats analyst expectations on active user growth
NXDR•
Distribution Solutions Q3 revenue rises on organic growth and acquisitions
DSGR•
3M Company: Deutsche Bank raises target price to $216 from $197
MMM•
Charles River Laboratories International: Deutsche Bank raises target price to $350 from $320
CRL•